- Updated version 1 – KKR achieves record-high profits as asset sales and management fees surge
- BUZZ – US Stock Market Updates: Nvidia, Genmab, Eli Lilly
- BUZZ-Sable Offshore shares fall as refinery shutdown hampers crude sales, putting pressure on cash flow
- SYLVAMO CORP <SLVM.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $47.00 FROM $40.00
- HAEMONETICS CORP <HAE.N>: RAYMOND JAMES RAISES TARGET PRICE TO $144 FROM $125
- ICHOR HOLDINGS, LTD. <ICHR.O>: D.A. DAVIDSON ASSUMES COVERAGE WITH BUY RATING; PRICE TARGET $37 VS $85
- ICF INTERNATIONAL, INC. <ICFI.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $90.00 FROM $80.00
- OSHKOSH CORP <OSK.N>: RAYMOND JAMES CUTS TARGET PRICE TO $165 FROM $170
- FLUOR <FLR.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $62.00 FROM $71.00
- EOG RESOURCES, INC. <EOG.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $166.00 FROM $160.00
- ACADIA HEALTHCARE COMPANY, INC. : RAYMOND JAMES RAISES TARGET PRICE TO $43 FROM $39
- DRAFTKINGS INC. <DKNG.O>: TRUIST SECURITIES CUTS TARGET PRICE TO $22.00 FROM $26.00
- DEVON ENERGY CORPORATION <DVN.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $62.00 FROM $61.00
- CONOCOPHILLIPS <COP.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $142.00 FROM $136.00
- KKR’s third-quarter operating earnings reach $1.74 billion, exceeding expectations
- Abcourt Mines Secures Authorization to Begin Drilling at Malartic JV
- Annovis Bio expects cash to fund operations through March 2027 Alzheimer's trial readout
- Viking Therapeutics plans VK2735 obesity trial presentations at ObesityWeek 2026
- NEXSTAR MEDIA GROUP INC <NXST.O>: DEUTSCHE BANK CUTS TARGET PRICE TO $233 FROM $240
- Beyond Oil Plans Private Placement of Up to CAD 20 Million
- Immunovant fiscal Q2 net loss narrows 23% to $97.25 million
- PyroGenesis Wins Titanium Powder Supply Contract With Global Aerospace Leader
- Prospectiva Identifies New Geophysical Targets at São Francisco Copper-Gold Project
- Ocular Therapeutix Appoints Riad Sherif to Board of Directors
- GCM Grosvenor Q3 2026 GAAP Net Income Rises
- Nkarta reports moderate or major responses in 5 of 6 myositis patients in NKX019 trial
- Aura Minerals Announces Dividend of R$ 1.314528 per Unit
- Kamada Q3 Net Income Jumps 51% to $7.99 Million
- Kamada Declares Cash Dividend of $0.14 Per Share
- Editas Medicine Q3 2026 net loss attributable to common stockholders narrows 7% to $23.4 million
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- Atea Pharmaceuticals secures credit facility of up to $200 million from Hercules Capital
- ACADIA HEALTHCARE COMPANY, INC. : DEUTSCHE BANK RAISES TARGET PRICE TO $46 FROM $32
- TERAWULF INC. <WULF.O>: ROSENBLATT SECURITIES CUTS TARGET PRICE TO $20 FROM $30
- Graphite One Targets First Sales From Ohio Graphite Plant in Fourth Quarter 2028
- GoldInxs Appoints Deepak Malhotra, Zoran Pudar and Gordana Slepcev to Board
- Aura Biosciences Q3 net loss widens 23% to $32.07 million
- Immunocore to Attend UBS and Jefferies Investor Conferences
- C3 Metals identifies new magnetic and gravity anomalies at Khaleesi copper project in Peru
- COREWEAVE, INC. <CRWV.O>: ROSENBLATT SECURITIES CUTS TARGET PRICE TO $160 FROM $250
- DoubleU Games replaces prior DoubleDown proposal with USD 16.25-per-ADS cash tender offer
- Hain Celestial Q1 FY27 net loss narrows 45% to $11.3 million; net sales fall 29% to $260.27 million
- Nextech3D.ai Corrects Share Hold Period Expiry to March 7, 2027
- Ocular Therapeutix 3Q Rev $12.9M >OCUL
- CEREBRAS SYSTEMS INC <CBRS.O>: ROSENBLATT SECURITIES CUTS TARGET PRICE TO $170 FROM $300
- Scotia Metals starts drilling at Acadia lithium project ahead of schedule
- Sasquatch Resources to Acquire Echo Property for 1,250,000 Shares
- Military Metals Announces Private Placement of Up to $1.5 Million
- IAMBIC THERAPEUTICS, INC. <IAM.O>: CITIGROUP INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $22
- Village Farms Names Hamid Shekarchi Interim CFO
- AMN HEALTHCARE SERVICES, INC. : BMO RAISES TARGET PRICE TO $52 FROM $43
- Turn Therapeutics Q3 net loss more than triples to $6.23 million
- Fredonia Mining begins pre-feasibility work for El Dorado-Monserrat gold-silver project
- Select Water Solutions Q3 2026 net income rises year-over-year to $22.93 million; Q3 2026 revenue climbs 28% to $412.19 million year-over-year
- BlackSky to Participate in Three Investor Conferences
- GBC Rates Reply Buy With EUR 185 Price Target
- Sky Harbour Plans Two New Hangar Campuses at Los Angeles' Van Nuys Airport
- Air Industries Group 3Q Sales $14.6M >AIRI
- Turn Therapeutics 3Q Loss/Shr 21c >TTRX
- Ceco Environmental 3Q Sales $404.4M >CECO
- Dow Jones Top Energy Headlines at 7 AM ET: Oil Prices Fall, Staying Below $100, After Trump Downplays Prospect of New Iran Strikes | Energy ...
- Via Transportation 3Q Loss $18.8M >VIA
- Via Transportation 3Q Rev $143.5M >VIA
- Ionis Pharmaceuticals 3Q Rev $243M >IONS
- Ionis Pharmaceuticals 3Q Loss/Shr 66c >IONS
- Hain Celestial 1Q Loss/Shr 12c >HAIN
- Hain Celestial 1Q Sales $260.3M >HAIN
- NRG Energy: Six Assets Represent 4.9 GW of Generation >NRG
- -- GUIDANCE: (VIA) Via Transportation, Inc. Expects Q4 Platform Revenue Range $150.0M - $151.7M
- -- Earnings Flash (OCUL) Ocular Therapeutix, Inc. Reports Q3 Revenue $12.9M, vs. FactSet Est of $14.3M
- --NRG Energy Selling 6 Natural Gas Generation Assets to LS Power for $4 Billion
- --Earnings Flash (OCUL) Ocular Therapeutix Posts Q3 Net Loss $0.42 a Share, vs. FactSet Est of $0.36 Loss
- --Earnings Flash (FRVO) Fervo Energy Posts Q3 Loss $0.07 a Share, vs. FactSet Est $0.07 Loss
- -- Earnings Flash (FRVO) Fervo Energy Company Reports Q3 Revenue $116,000
- JPMorgan Downgrades DraftKings to Neutral From Overweight, $21 Price Target
- -- Earnings Flash (WTTR) Select Water Solutions, Inc. Reports Q3 Revenue $412.2M, vs. FactSet Est of $398.0M
- --Earnings Flash (WTTR) Select Water Solutions Posts Q3 EPS of $0.16, vs. FactSet Est of $0.18
- SharpLink's Q3 Earnings, Revenue Increase
- --GUIDANCE: (MNDY) Monday.com Expects 2026 Revenue Range $1.47B - $1.48B, vs. FactSet Est of $1.47B
- --Earnings Flash (IMVT) Immunovant Posts Fiscal Q2 Loss $0.47 a Share, vs. FactSet Est of $0.74 Loss
- Hannan Metals to Begin Trading on OTCQB Venture Market
- -- Earnings Flash (VRTS) Virtus Investment Partners, Inc. Posts Q3 Adjusted EPS $5.86 per Share, vs. FactSet Est of $5.78
- TD Cowen Upgrades South Bow to Buy From Hold, Price Target is CA$51
- -- Earnings Flash (CEVA) Ceva, Inc. Reports Q3 Revenue $29.1M, vs. FactSet Est of $32.7M
- -- Earnings Flash (VRTS) Virtus Investment Partners, Inc. Reports Q3 Revenue $197.6M, vs. FactSet Est of $181.4M
- -- Earnings Flash (CEVA) Ceva, Inc. Posts Q3 Adjusted EPS $0.13 per Share, vs. FactSet Est of $0.19
- -- Earnings Flash (VIA) Via Transportation, Inc. Posts Q3 Adjusted EPS $0.00 per Share
- -- Earnings Flash (VIA) Via Transportation, Inc. Reports Q3 Revenue $143.5M, vs. FactSet Est of $137.9M
- --Earnings Flash (IONS) Ionis Pharmaceuticals Posts Q3 Loss $0.66 a Share, vs. FactSet Est of $1.23 Loss
- -- Earnings Flash (RBY.TO) Rubellite Energy Corp. Reports Q3 Revenue CA$81.7M
- -- Earnings Flash (RBY.TO) Rubellite Energy Posts Q3 Net Loss CA$0.29 a Share
- -- Earnings Flash (CECO) CECO Environmental Corp. Reports Q3 Revenue $404.4M, vs. FactSet Est of $399.6M
- --Earnings Flash (TGTX) TG Therapeutics Posts Q3 EPS $0.35, vs. FactSet Est of $0.37
- --Earnings Flash (ROIV) Roivant Posts Fiscal Q2 Net Loss $0.27 a Share
- -- Earnings Flash (CECO) CECO Environmental Corp. Posts Q3 Adjusted EPS $0.60 per Share, vs. FactSet Est of $0.59
- --RBC Raises Price Target on Sylvamo to $37 From $35, Keeps Sector Perform Rating
- ImmunityBio Says Anktiva Combination Therapy Meets Primary Endpoint in Non-Muscle Invasive Bladder Cancer Trial
